Advanced Enzyme Technologies Ltd. Conference Calls and Earnings Call Transcripts

Advanced Enzyme Technologies Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Advanced Enzyme Technologies Ltd.
03 Jun 2020
303.60
-0.25%
Earnings Call Transcript - Q4FY20 for Advanced Enzyme Technologies

Conference Call with Advanced Enzyme Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript. 

video
 
logo
Advanced Enzyme Technologies Ltd.
14 Feb 2020
303.60
-0.25%
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Earning Call Transcript Advanced Enzyme Technologies Limited Q3FY2020

Opening Remarks from Management

We have considerable growth in terms of profitability. This is mainly because of the product mix. Our business in India had positive results and has been up by 15%. Evoxx, which is our subsidiary in Germany, is EBITDA positive in the current quarter as compared to the previous quarter and growing steadily. The EBIT for Evoxx is also on the positive side.

Our sales on year-to-year basis is on positive side and has an upstream of Rs.102 million and has grown from Rs.1017 million to Rs.1119 million that is approximately 10% growth in the revenue. Correspondingly, the EBITDA has increased by Rs.112 million from Rs.417 million to Rs.529 million, and that is approximately 27% growth in EBITDA and as a percentage of total sales, EBITDA is having a percentage of 47% as compared to 41%. Our consolidated PAT for this quarter has also increased by 37% from Rs.253 million to Rs.346 million in the current quarter.

Click pdf to read full transcript
pdf
logo
Advanced Enzyme Technologies Ltd.
08 Nov 2019, 04:20PM
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
19 Aug 2019
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
30 May 2019
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
15 Nov 2018
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
20 Aug 2018
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
08 Feb 2018, 05:30PM
303.60
-0.25%
pdf
logo
Advanced Enzyme Technologies Ltd.
13 Sep 2017
303.60
-0.25%
Earnings Call Transcript
BSE India
Advanced Enzyme Technologies Limited Q1 FY2018 Earnings Conference Call Transcript
pdf

Earnings Calls Podcast on